Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Brecht

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Endocrinology|November 20, 2025
European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT groupMichaela Kuhlen, Calogero Virgone, Charlotte Rigaud, et al.
Pediatric Blood & Cancer|April 7, 2021
Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsGianni Bisogno, Sabine Sarnacki, Teresa Stachowicz-Stencel, et al.
Pediatric Blood & Cancer|April 12, 2021
Nasopharyngeal carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsTal Ben-Ami, Udo Kontny, Aurore Surun, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II TrialTim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
European Journal of Human Genetics : EJHG|July 28, 2023
Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patientsChristopher Schroeder, Ulrike Faust, Luisa Krauße, et al.
Ebiomedicine|September 16, 2023
UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescentsAlexandra Liebmann, Jakob Admard, Sorin Armeanu-Ebinger, et al.
Journal of Medical Genetics|June 29, 2022
Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working GroupLéa Guerrini-Rousseau, Julien Masliah-Planchon, Sebastian M Waszak, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2024
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)Mario Mandalà, Andrea Ferrari, Ines B Brecht, et al.
Cancers|April 30, 2021
Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and AustriaMadlen Reschke, Eva Biewald, Leo Bronstein, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Endocrinology|November 20, 2025
European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT groupMichaela Kuhlen, Calogero Virgone, Charlotte Rigaud, et al.
Pediatric Blood & Cancer|April 7, 2021
Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsGianni Bisogno, Sabine Sarnacki, Teresa Stachowicz-Stencel, et al.
Pediatric Blood & Cancer|April 12, 2021
Nasopharyngeal carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsTal Ben-Ami, Udo Kontny, Aurore Surun, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II TrialTim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
European Journal of Human Genetics : EJHG|July 28, 2023
Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patientsChristopher Schroeder, Ulrike Faust, Luisa Krauße, et al.
Ebiomedicine|September 16, 2023
UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescentsAlexandra Liebmann, Jakob Admard, Sorin Armeanu-Ebinger, et al.
Journal of Medical Genetics|June 29, 2022
Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working GroupLéa Guerrini-Rousseau, Julien Masliah-Planchon, Sebastian M Waszak, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2024
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)Mario Mandalà, Andrea Ferrari, Ines B Brecht, et al.
Cancers|April 30, 2021
Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and AustriaMadlen Reschke, Eva Biewald, Leo Bronstein, et al.
Pageof 10